Variant report
Variant | nsv551866 |
---|---|
Chromosome Location | chr10:90944659-90948014 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:90807595..90810361-chr10:90944518..90946449,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10788636 | chr10:90944659-90944660 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs34137383 | chr10:90944708-90944709 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs142193209 | chr10:90944796-90944797 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs180851463 | chr10:90944820-90944821 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs541516336 | chr10:90944886-90944887 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs74821185 | chr10:90944894-90944895 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs377743565 | chr10:90944915-90944916 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs374299647 | chr10:90944925-90944926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs151227281 | chr10:90944983-90944984 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs114005928 | chr10:90944998-90944999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs367591337 | chr10:90945005-90945006 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183968341 | chr10:90945018-90945019 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564494989 | chr10:90945021-90945022 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs530150373 | chr10:90945024-90945025 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs542282050 | chr10:90945037-90945038 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs35064463 | chr10:90945076-90945077 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs563537305 | chr10:90945108-90945109 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs188302083 | chr10:90945167-90945168 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs552281797 | chr10:90945181-90945182 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs570462118 | chr10:90945206-90945207 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs140282114 | chr10:90945212-90945213 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546425162 | chr10:90945279-90945280 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs150357904 | chr10:90945349-90945350 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs77230444 | chr10:90945359-90945360 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs368183151 | chr10:90945396-90945397 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556975457 | chr10:90945442-90945443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs76937316 | chr10:90945465-90945466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs578046583 | chr10:90945513-90945514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs138866060 | chr10:90945516-90945517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs140634288 | chr10:90945523-90945524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs145701301 | chr10:90945531-90945532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs562595776 | chr10:90945535-90945536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs553625759 | chr10:90945558-90945559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs574929803 | chr10:90945585-90945586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541968862 | chr10:90945629-90945630 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
36 | rs563846836 | chr10:90945647-90945648 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
37 | rs138172622 | chr10:90945660-90945661 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
38 | rs35184961 | chr10:90945681-90945682 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
39 | rs149568572 | chr10:90945705-90945706 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
40 | rs372859199 | chr10:90945706-90945707 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
41 | rs116209171 | chr10:90945751-90945752 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
42 | rs10509567 | chr10:90945756-90945757 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs546441335 | chr10:90945776-90945777 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545721820 | chr10:90945777-90945778 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
45 | rs561552660 | chr10:90945789-90945790 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
46 | rs10788637 | chr10:90945808-90945809 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs550496232 | chr10:90945814-90945815 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
48 | rs547058800 | chr10:90945844-90945845 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
49 | rs10887928 | chr10:90945861-90945862 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs114689766 | chr10:90945882-90945883 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Lung cancer | 18438408 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Usher syndrome | 20538994 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Paraganglioma | 17535989 | CNVD |
Submicroscopic aberration syndrome | 21292638 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Colorectal cancer | 18645599 | CNVD |
Polyposis syndrome | 18645599 | CNVD |
Prostate cancer | 17245344 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 22032731 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Wilms tumour | 21544195 | CNVD |
Cancer | 20164919 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neurocytoma | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Basal-like breast cancer | 18066063 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Lung cancer | 21911935 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 22048815 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Cervical cancer | 21062161 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 24453001 | CNVD |
Breast cancer | 16608533 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:90943600-90945000 | Enhancers | Osteobl | bone |
2 | chr10:90943800-90945400 | Weak transcription | NHLF | lung |
3 | chr10:90944000-90945200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
4 | chr10:90944400-90949400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
5 | chr10:90945200-90945800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr10:90945200-90946000 | Enhancers | Stomach Smooth Muscle | stomach |
7 | chr10:90945400-90945600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
8 | chr10:90945400-90945800 | Enhancers | Duodenum Smooth Muscle | Duodenum |
9 | chr10:90945400-90945800 | Enhancers | Hela-S3 | cervix |
10 | chr10:90945400-90946600 | Enhancers | Fetal Lung | lung |
11 | chr10:90945600-90945800 | Enhancers | Sigmoid Colon | Sigmoid Colon |
12 | chr10:90945600-90945800 | Enhancers | NHLF | lung |
13 | chr10:90945600-90946000 | Enhancers | Colon Smooth Muscle | Colon |
14 | chr10:90945600-90946000 | Bivalent Enhancer | Stomach Mucosa | stomach |
15 | chr10:90946200-90947200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
16 | chr10:90946400-90946800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
17 | chr10:90946400-90947000 | Enhancers | H1 Cell Line | embryonic stem cell |
18 | chr10:90946400-90947000 | Enhancers | H9 Cell Line | embryonic stem cell |